Massachusetts Innovation Network Announces its 2022 Eddies Finalists
LINCOLN, Mass.–(BUSINESS WIRE)–Massachusetts Innovation Network has announced the finalists for its signature innovation competition, The…
News
Pavilion Enables EngineRoom to Turbocharge HPC-as-a-Service
With Pavilion HyperOS and HyperParallel Flash Array, EngineRoom can utilize their GPUs to the fullest…
SkyWater Announces Availability of SRAM Memory Compiler for 90 nm Strategic Rad Hard by Process Offering
Mobile Semiconductor provides IP for SkyWater’s customers developing strategic space, defense and high reliability programs…
US DOE Closes $504.4 Million Loan to Advanced Clean Energy Storage Project for Hydrogen Production and Storage
The U.S. Department of Energy’s Loan Programs Office makes its first loan in ten years…
Now Introducing: The T-Mobile 5G Hotspot
Snag the Un-carrier’s 5G Hotspot for the low, low price of FREE BELLEVUE, Wash.–(BUSINESS WIRE)–T-Mobile…
Better Choice Reminds Shareholders to Vote on Annual Meeting Proposals Before the Proxy Deadline of June 12, 2022
NEW YORK, June 09, 2022 (GLOBE NEWSWIRE) — Better Choice Company Inc. (NYSE: BTTR) (the…
Morphic to Present at 2022 Jefferies Global Healthcare Conference
WALTHAM, Mass., June 09, 2022 (GLOBE NEWSWIRE) — Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company…
TransCode Therapeutics to Participate at BIO International Convention
BOSTON, June 09, 2022 (GLOBE NEWSWIRE) — TransCode Therapeutics, Inc. (Nasdaq: RNAZ) today announced that…
BioNTech to Provide an Update on Manufacturing and Development Plans of mRNA Vaccines in Africa
MAINZ, Germany, June 9, 2022 (GLOBE NEWSWIRE) — BioNTech SE (Nasdaq: BNTX, “BioNTech”) will welcome its…
Novan Announces Approximately $15.0 Million Registered Direct Offering Priced At-the-Market
DURHAM, N.C., June 09, 2022 (GLOBE NEWSWIRE) — Novan, Inc. (“the Company” or “Novan”) (Nasdaq:…
SciSparc’s Board of Directors Provides Strategic Decision
TEL AVIV, Israel, June 09, 2022 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC), a specialty…
Cend Therapeutics Announces First Patient Treated in Phase 2b Trial of CEND-1 led by Australasian Gastro-Intestinal Trials Group
SAN DIEGO, June 09, 2022 (GLOBE NEWSWIRE) — Cend Therapeutics, Inc. (“Cend”) today announced that…
Eyenovia Announces Virtual 2022 Annual Meeting of Stockholders
NEW YORK, June 09, 2022 (GLOBE NEWSWIRE) — Eyenovia, Inc. (NASDAQ: EYEN), an ophthalmic pharmaceutical…
Impel Pharmaceuticals to Present Trudhesa® Data at the 64th Annual Meeting of the American Headache Society
Oral Presentation Showcases Early Ability to Predict Responders to Trudhesa New Analysis Suggest Patient-Reported Benefits…
Caladrius Biosciences Announces Merger Partner, Cend Therapeutics, has Treated First Patient in Phase 2b Trial of CEND-1 in Collaboration with Australasian Gastro-Intestinal Cancer Trials Group
BASKING RIDGE, N.J., June 09, 2022 (GLOBE NEWSWIRE) — Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius”…
Entasis Therapeutics Presents Data on Sulbactam-Durlobactam and ETX0462 at 2022 ASM Microbe Annual Conference
WALTHAM, Mass., June 09, 2022 (GLOBE NEWSWIRE) — Entasis Therapeutics Holdings Inc. (Nasdaq: ETTX), a late-stage…
TFF Pharmaceuticals to Participate at The JMP Securities Life Sciences Conference
FORT WORTH, Texas, June 09, 2022 (GLOBE NEWSWIRE) — TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage…
Eledon Pharmaceuticals Announces Orphan Drug Designation Granted to Tegoprubart for the Prevention of Allograft Rejection in Pancreatic Islet Cell Transplantation
IRVINE, Calif., June 09, 2022 (GLOBE NEWSWIRE) — Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), a…
Tempest Provides ASCO KOL Feedback on TPST-1120 Clinical Results and Updated Financial Guidance
TPST-1120 demonstrated monotherapy clinical benefit in patients with late-line advanced, poor-prognosis cancers where responses would…
PROCEPT BioRobotics Corporation Announces Additional Positive Coverage Policies Regarding Aquablation Therapy for Men with Enlarged Prostates
REDWOOD CITY, Calif., June 09, 2022 (GLOBE NEWSWIRE) — PROCEPT® BioRobotics Corporation (Nasdaq: PRCT), a surgical…